Medicare Enrolled
Dr. Jeremy Jaffe, M.D.
Optician · Abington, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jaffe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jaffe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jaffe
Dr. Jeremy Jaffe is an optician specialist in Abington, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Jaffe performed 11,957 Medicare services across 3,599 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jaffe received a total of $23,217 from 71 pharmaceutical and/or device companies across 1068 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jaffe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 2% volume in PA
$23,217 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,957
Medicare services
Top 2% in PA for optician
3,599
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~569 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
2,811 | $4 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,698 | $102 | $652 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,307 | $1 | $6 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,188 | $52 | $205 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
943 | $60 | $300 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
571 | $110 | $575 |
| Contrast dye for imaging, lower concentration | 280 | $0 | $3 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
207 | $15 | $77 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
190 | $153 | $786 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
186 | $238 | $1,000 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
149 | $40 | $199 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
136 | $9 | $189 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
124 | $219 | $1,407 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
119 | $797 | $5,750 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
115 | $151 | $905 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
111 | $133 | $844 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
105 | $238 | $1,669 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
97 | $52 | $334 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
79 | $202 | $1,616 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
71 | $108 | $852 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
68 | $151 | $1,056 |
| New patient office visit, complex (60-74 min) | 63 | $184 | $1,114 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
61 | $71 | $461 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
51 | $220 | $982 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
48 | $99 | $620 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
46 | $100 | $610 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
41 | $65 | $453 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $72 | $459 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
29 | $407 | $2,520 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
27 | $225 | $1,425 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,217
Total received (2018-2024)
Avg $3,317/year across 7 years
Top 9% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,068
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,052 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,651
2023
$4,627
2022
$5,735
2021
$3,695
2020
$1,632
2019
$2,626
2018
$1,252
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$805
Collegium Pharmaceutical, Inc.
$656
Vertos Medical, Inc.
$537
Boston Scientific Corporation
$270
Valinor Pharma, LLC
$201
PFIZER INC.
$183
Teva Pharmaceuticals USA, Inc.
$164
IBSA Pharma Inc.
$143
ABBVIE INC.
$133
SCILEX PHARMACEUTICALS INC.
$132
Averitas Pharma Inc.
$85
Stryker Corporation
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$58
VERTEX PHARMACEUTICALS INCORPORATED
$55
Neurocrine Biosciences, Inc.
$45
Avanos Medical
$43
Lilly USA, LLC
$38
SI-BONE, INC.
$27
Medtronic, Inc.
$14
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$9,038
Collegium Pharmaceutical, Inc.
$2,513
Boston Scientific Corporation
$1,590
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,394
Vertos Medical, Inc.
$1,071
ABBVIE INC.
$834
Scilex Pharmaceuticals Inc.
$584
USWM, LLC
$430
IBSA Pharma Inc.
$400
Teva Pharmaceuticals USA, Inc.
$362
PFIZER INC.
$354
Valinor Pharma, LLC
$278
Radius Health, Inc.
$264
BOSTON SCIENTIFIC CORPORATION
$262
Daiichi Sankyo Inc.
$237
Kaleo, Inc.
$193
SCILEX PHARMACEUTICALS INC.
$169
Averitas Pharma Inc.
$165
Biohaven Pharmaceutical Holding Company Ltd.
$155
US WorldMeds, LLC
$145
Takeda Pharmaceuticals U.S.A., Inc.
$142
Amarin Pharma Inc.
$125
RedHill Biopharma Inc.
$122
GRT US Holding, Inc.
$115
Forte Bio-Pharma LLC
$110
Lilly USA, LLC
$109
Egalet US Inc
$106
Medtronic USA, Inc.
$105
Kowa Pharmaceuticals America, Inc.
$102
E.R. Squibb & Sons, L.L.C.
$99
Stryker Corporation
$97
AbbVie Inc.
$97
Nalu Medical, Inc.
$82
Nevro Corp.
$82
Almatica Pharma LLC
$77
Vertiflex, Inc.
$66
Medtronic, Inc.
$65
SI-BONE, INC.
$63
Purdue Pharma L.P.
$63
Currax Pharmaceuticals LLC
$61
AstraZeneca Pharmaceuticals LP
$60
Zyla Life Sciences
$56
VERTEX PHARMACEUTICALS INCORPORATED
$55
Biohaven Pharmaceuticals, Inc.
$50
Neurocrine Biosciences, Inc.
$45
PAINTEQ LLC
$45
Avanos Medical
$43
Shionogi Inc
$41
ARBOR PHARMACEUTICALS, INC.
$41
PROTEGA PHARMACEUTIALS LLC
$37
Trevena, Inc.
$32
Pacira Pharmaceuticals Incorporated
$30
Arbor Pharmaceuticals, Inc.
$30
Amgen Inc.
$28
Flexion Therapeutics, Inc.
$25
Vertical Pharmaceuticals, LLC
$25
TerSera Therapeutics LLC
$23
Foundation Fusion Solutions, LLC
$22
Stimwave Technologies Incorporated
$20
Amneal Pharmaceuticals LLC
$20
Relievant Medsystems, Inc.
$20
West Therapeutics Development, LLC
$19
PROTEGA PHARMACEUTIALS INC
$18
INSYS Therapeutics Inc
$16
Virtus Pharmaceuticals LLC
$15
Siemens Medical Solutions USA, Inc.
$15
Merck Sharp & Dohme Corporation
$14
ASSERTIO THERAPEUTICS, INC.
$14
Azurity Pharmaceuticals, Inc.
$14
Sentynl Therapeutics, Inc.
$13
Electronic Waveform Lab, Inc.
$8
Top 3 companies account for 56.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · ARYMO ER · AUSTEDO · Aimovig · Amitiza · Austedo XR · BOTOX · BRIDION · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · CONTRAVE · ELIQUIS · EMGALITY · ETERNA · EVZIO · EXCLAIM · Eon Family of SCS IPGs · Evzio · Exclaim SCS Leads · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · General - Pain Management · Gralise · HYSINGLA ER · Horizant · INGREZZA · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Intracept · Iovera · LACTULOSE · LAMITRODE · LICART · LORZONE · LYRICA · LYVISPAH · Lamitrode SCS Leads · Lazanda · Levorphanol · Lucemyra · Lucemyra/Lofexidine · MAGNETOM Free.Max · MILD DEVICE KIT · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · OXYCONTIN · Octrode SCS Leads · Olinvyk · PAINTEQ · PAXLOVID · PENTA · PRIALT · PROCLAIM · PRODIGY · PROLATE · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim XR IPG · Prodigy Family of SCS IPGs · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Quattrode Leads SCS Leads · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ROXYBOND · Roxybond · SCS leads · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SUBSYS · SUPERION · SYMPROIC · Seglentis · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · Tirosint · Tymlos · UBRELVY · Vascepa · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZIMHI · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in PA.
Geographic Context
Opticians within 10 mi
725
Per 100K population
84.2
County median income
$111,521
Nearest hospital
JEFFERSON ABINGTON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jaffe is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with low-engagement industry engagement in the top 9% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jaffe experienced with assessment of emotional or behavioral problems?
Based on Medicare claims data, Dr. Jaffe performed 2,811 assessment of emotional or behavioral problems services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jaffe receive payments from pharmaceutical companies?
Yes. Dr. Jaffe received a total of $23,217 from 71 companies across 1,068 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jaffe's costs compare to other opticians in Abington?
Dr. Jaffe's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jaffe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Abington
Browse opticians in Abington ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology